Bank of Nova Scotia’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.8M | Buy |
+241,985
| New | +$8.8M | 0.02% | 408 |
|
|
2023
Q4 | – | Sell |
-42,451
| Closed | -$1.51M | – | 1028 |
|
|
2023
Q3 | $1.51M | Buy |
+42,451
| New | +$1.51M | ﹤0.01% | 632 |
|
|
2023
Q2 | – | Sell |
-38,200
| Closed | -$1.53M | – | 1111 |
|
|
2023
Q1 | $1.53M | Sell |
38,200
-61,000
| -61% | -$2.45M | ﹤0.01% | 605 |
|
|
2022
Q4 | $4.6M | Hold |
99,200
| – | – | 0.01% | 492 |
|
|
2022
Q3 | $4.11M | Buy |
99,200
+60,897
| +159% | +$2.52M | 0.01% | 461 |
|
|
2022
Q2 | $2.28M | Buy |
+38,303
| New | +$2.28M | 0.01% | 657 |
|